A Study of Intravenous Tamiflu (Oseltamivir) in Children With Influenza
Public ClinicalTrials.gov record NCT01033734. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open Label, Prospective, Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Oseltamivir (Tamiflu) in the Treatment of Children 1 to 12 Years of Age With Influenza Infection
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This open-label study will assess the pharmacokinetics/pharmacodynamics and safety of intravenous (iv) Tamiflu (oseltamivir) in 3 cohorts of children, aged 6-12, 3-5 and 1-2 years, with influenza infection. Patients will receive iv Tamiflu therapy for 5 days (10 doses). For patients whose conditions no longer merit continued iv dosing, therapy may be switched to oral Tamiflu to complete their prescribed course of treatment. If medically necessary, iv or oral therapy with Tamiflu may be continued for up to 5 additional days. Anticipated time on study treatment is 5 to 10 days.
Study identification
- NCT ID
- NCT01033734
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 8 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 1 Year to 12 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2010
- Primary completion
- Nov 30, 2012
- Completion
- Nov 30, 2012
- Last update posted
- Aug 23, 2016
2010 – 2012
United States locations
- U.S. sites
- 36
- U.S. states
- 23
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Los Angeles | California | 90095 | — |
| Not listed | Oakland | California | 94609-1809 | — |
| Not listed | Aurora | Colorado | 80045 | — |
| Not listed | Wilmington | Delaware | 19803 | — |
| Not listed | Jacksonville | Florida | 32209 | — |
| Not listed | Chicago | Illinois | 60611 | — |
| Not listed | South Bend | Indiana | 46601 | — |
| Not listed | Wichita | Kansas | 67214 | — |
| Not listed | Louisville | Kentucky | 40202 | — |
| Not listed | Boston | Massachusetts | 02111 | — |
| Not listed | Boston | Massachusetts | 02115 | — |
| Not listed | Boston | Massachusetts | 02118 | — |
| Not listed | Springfield | Massachusetts | 01199 | — |
| Not listed | Detroit | Michigan | 48201 | — |
| Not listed | Duluth | Minnesota | 55805 | — |
| Not listed | Omaha | Nebraska | 68131 | — |
| Not listed | Morristown | New Jersey | 07960 | — |
| Not listed | Brooklyn | New York | 11203 | — |
| Not listed | New York | New York | 10016 | — |
| Not listed | Stony Brook | New York | 11794-8161 | — |
| Not listed | Syracuse | New York | 13210 | — |
| Not listed | The Bronx | New York | 10461 | — |
| Not listed | Durham | North Carolina | 27705 | — |
| Not listed | Raleigh | North Carolina | 27610 | — |
| Not listed | Akron | Ohio | 44308 | — |
| Not listed | Cleveland | Ohio | 44106 | — |
| Not listed | Dayton | Ohio | 45404 | — |
| Not listed | Toledo | Ohio | 43606 | — |
| Not listed | Toledo | Ohio | 43608 | — |
| Not listed | Oklahoma City | Oklahoma | 73104 | — |
| Not listed | Tyrone | Pennsylvania | 16686 | — |
| Not listed | Providence | Rhode Island | 02903 | — |
| Not listed | Charleston | South Carolina | 29524 | — |
| Not listed | Houston | Texas | 77030 | — |
| Not listed | Richmond | Virginia | 23298 | — |
| Not listed | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01033734, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 23, 2016 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01033734 live on ClinicalTrials.gov.